Climb Bio, Inc.

CLYMNASDAQHealthcare● Active

$10.77

+$0.22(+2.09%)

Market Cap$734346333

P/E Ratio—

52W High$12.48

52W Low$1.16

Avg Volume785K

Open$11.05

Beta0.12

Overview

Climb Bio, Inc.（CLYM）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CLYM · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.75

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 43%仅显示有效交易 · 排除RSU归属57% Sell ↓

Climb Bio, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

CLYM 季度内部人买卖趋势

CLYM 内幕交易卖出 · CLYM 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

21.4M10.7M0

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · CLYM CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

CLYM 高管卖出股份 · CLYM 董事内幕交易 · SEC Form 4申报

显示最近 20 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Feb 25, 2026	Thomas Stephen Basil Director	Sale	33,687	$7.00	$236K	170,970	Form 4
Feb 26, 2026	Thomas Stephen Basil Director	Sale	16,313	$7.01	$114K	154,657	Form 4
Feb 12, 2026	Thomas Stephen Basil Director	Sale	90,000	$5.23	$471K	214,657	Form 4
Feb 13, 2026	Thomas Stephen Basil Director	Sale	10,000	$5.81	$58K	204,657	Form 4
Jan 5, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Purchase	7,111	$3.50	$25K	3,403,429	Form 4
Dec 12, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Purchase	101,462	$2.86	$290K	3,396,318	Form 4
Dec 11, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Purchase	213,099	$2.18	$465K	3,294,856	Form 4
Dec 11, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Other	20,440,000	—	—	3,081,757	Form 4
Aug 7, 2025	Thomas Stephen Basil Director	Award	100,375	—	—	304,657	Form 4
Jun 27, 2025	Brennan Aoife President and CEO · Director	Option	68,750	—	—	68,750	Form 4
Jun 30, 2025	Brennan Aoife President and CEO · Director	Sale	20,618	$1.22	$25K	48,132	Form 4
Jun 27, 2025	Thomas Stephen Basil Director	Option	25,094	—	—	204,282	Form 4
Jun 18, 2025	Pimblett Emily SVP, Finance & CAO	Option	5,000	—	—	20,130	Form 4
Jun 20, 2025	Pimblett Emily SVP, Finance & CAO	Sale	1,242	$1.24	$2K	18,888	Form 4
Mar 27, 2025	Thomas Stephen Basil Director	Option	25,093	—	—	179,188	Form 4
Mar 18, 2025	Pimblett Emily SVP, Finance & CAO	Option	5,000	—	—	16,329	Form 4
Mar 20, 2025	Pimblett Emily SVP, Finance & CAO	Sale	1,199	$1.31	$2K	15,130	Form 4
Jan 1, 2025	Thomas Stephen Basil Director	Option	50,188	—	—	154,095	Form 4
Dec 18, 2024	Pimblett Emily CHIEF ACCOUNTING OFFICER	Option	5,000	—	—	12,564	Form 4
Dec 19, 2024	Pimblett Emily CHIEF ACCOUNTING OFFICER	Sale	1,235	$2.02	$2K	11,329	Form 4

Thomas Stephen Basil

Director

Sale

日期

Feb 25

股数

33,687

均价

$7.00

总金额

$236K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Sale

日期

Feb 26

股数

16,313

均价

$7.01

总金额

$114K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Sale

日期

Feb 12

股数

90,000

均价

$5.23

总金额

$471K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Sale

日期

Feb 13

股数

10,000

均价

$5.81

总金额

$58K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Purchase

日期

Jan 5

股数

7,111

均价

$3.50

总金额

$25K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Purchase

日期

Dec 12

股数

101,462

均价

$2.86

总金额

$290K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Purchase

日期

Dec 11

股数

213,099

均价

$2.18

总金额

$465K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Other

日期

Dec 11

股数

20,440,000

均价

—

总金额

—

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Award

日期

Aug 7

股数

100,375

均价

—

总金额

—

View Form 4 on SEC.gov

Brennan Aoife

President and CEO · Director

Option

日期

Jun 27

股数

68,750

均价

—

总金额

—

View Form 4 on SEC.gov

Brennan Aoife

President and CEO · Director

Sale

日期

Jun 30

股数

20,618

均价

$1.22

总金额

$25K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Option

日期

Jun 27

股数

25,094

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

SVP, Finance & CAO

Option

日期

Jun 18

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

SVP, Finance & CAO

Sale

日期

Jun 20

股数

1,242

均价

$1.24

总金额

$2K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Option

日期

Mar 27

股数

25,093

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

SVP, Finance & CAO

Option

日期

Mar 18

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

SVP, Finance & CAO

Sale

日期

Mar 20

股数

1,199

均价

$1.31

总金额

$2K

View Form 4 on SEC.gov

Thomas Stephen Basil

Director

Option

日期

Jan 1

股数

50,188

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

CHIEF ACCOUNTING OFFICER

Option

日期

Dec 18

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Pimblett Emily

CHIEF ACCOUNTING OFFICER

Sale

日期

Dec 19

股数

1,235

均价

$2.02

总金额

$2K

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CLYM 内幕交易

CLYM 内幕交易

Climb Bio, Inc.（CLYM）内幕交易数据来源于公司内部人（包括Thomas Stephen Basil (Director), RA CAPITAL MANAGEMENT, L.P. (Director), Brennan Aoife (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。CLYM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Climb Bio, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CLYM 内幕交易 · 5个问题

Climb Bio, Inc.（CLYM）的内部人包括高管和董事，如Thomas Stephen Basil (Director), RA CAPITAL MANAGEMENT, L.P. (Director), Brennan Aoife (President and CEO · Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CLYM 董事内幕交易CLYM 内部人名单Climb Bio, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026